Imaging amyloidosis with radiolabelled SAP
- 1 July 1995
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 22 (7), 595-599
- https://doi.org/10.1007/bf01254559
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Treatment of amyloidosisAmerican Journal of Kidney Diseases, 1995
- The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.Journal of Clinical Investigation, 1994
- Structure of pentameric human serum amyloid P componentNature, 1994
- Serum amyloid p component scintigraphy and turnover studies for diagnosis and quantitative monitoring of aa amyloidosis in juvenile rheumatoid arthritisArthritis & Rheumatism, 1993
- Dialysis-related amyloidosisKidney International, 1992
- Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosisClinical and Experimental Immunology, 1991
- Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.Journal of Clinical Investigation, 1990
- DIAGNOSTIC RADIONUCLIDE IMAGING OF AMYLOID: BIOLOGICAL TARGETING BY CIRCULATING HUMAN SERUM AMYLOID P COMPONENTThe Lancet, 1988
- Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.The Journal of Experimental Medicine, 1988
- Imaging of experimental amyloidosis with 131i‐labeled serum amyloid p componentArthritis & Rheumatism, 1987